Impact of Gut Hormones and Inflammatory Adipokines in Obese Patients Underwent Bariatric Surgery

Gao Zhiguang

Status: Completed

Conditions: Chronic Inflammation; Obesity; Type 2 Diabetes

Treatments: Procedure: laparoscopic sleeve gastrectomy; Procedure: laparoscopic Roux-en-Y gastric bypass

Study type: Interventional

Funder types: Other

Identifiers

NCT02963662

2014A020212219

Details and patient eligibility

About

Obesity and type 2 diabetes, dyslipidemia and related metabolic disease has become a threat to our national life and health which is showing a trend. Bariatric Surgery had been confirmed definite therapeutic effect to obesity and type 2 diabetes. However, laparoscopic gastric bypass and laparoscopic sleeve gastrectomy have the similar outcome to type 2 diabetes, but the two surgical methods and principles are completely different, which mechanisms are not yet clear. Lots of literature report adipose tissue releases adipokines and inflammatory cytokines induced chronic inflammation and obesity-related complications (insulin resistance and Type 2 diabetes).It is not clear whether to change these gastrointestinal hormones, adipokines and secretion of inflammatory cytokines with the operation, which play a therapeutic effect of obesity-related complications and diabetes. In addition, the investigators are wonder whether gut hormones, adipokines and inflammatory cytokines have some correlation in different severity obese patients,. It is worth to explore that could intestinal hormones, adipokines and inflammatory factors levels guide us to choice the different surgical approach to different severity obese patients. The investigators tried to investigate different surgical methods to alleviate diabetes and other metabolic diseases mechanisms though hormones and inflammatory factors and adipose tissue inflammation level and compare the impact of intestinal hormones and inflammatory adipokines of the two surgical approaches.

Enrollment: 100 patients

Sex: All

Ages: 14 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• According to the standard of obesity Obesity Task Force established in 2001, BMI≥28k / m2 with obesity-related metabolic diseases in patients, or BMI≥35kg / m2 in patients with severe obesity were selected.
• The age of 14-65 years.
• Self-capacity, non-drug dependence, psychological illness.
• Not prompted stomach ulcers, erosions, tumors, polyps, atrophic gastritis and other stomach diseases in the preoperative endoscopy.
• No history of stomach and abdominal surgery.
• Case Source: First Affiliated Hospital of Jinan University, by the same team of doctors performed the surgical procedure.

Exclusion criteria

• Whom did not follow the inclusion criteria

Trial design

Primary purpose: Basic Science

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

100 participants in 3 patient groups

Roux-en-Y gastric bypass group

Experimental group

Description:

The patients undergo Roux-en-Y gastric bypass (RYGB group) following a comprehensive evaluation for the surgical indication

Treatment:

Procedure: laparoscopic Roux-en-Y gastric bypass

sleeve gastrectomy group

Experimental group

Description:

The patients undergo sleeve gastrectomy (SG group) following a comprehensive evaluation for the surgical indication

Treatment:

Procedure: laparoscopic sleeve gastrectomy

Normal BMI group

No Intervention group

Description:

no intervention